Skip to main content
SpringerLink
Log in

Uterine Leiomyome

Indikationen für konservative Therapieoptionen

Uterine leiomyoma

Indications for conservative therapy options

  • Leitthema
  • Published:
Der Gynäkologe Aims and scope

Zusammenfassung

Uterusmyome sind gutartige Tumoren der Uterusmuskulatur, die bei mehr als einem Drittel der Frauen auftreten. Als Behandlungsmöglichkeiten stehen neben der chirurgischen Entfernung die medikamentösen, v. a. endokrinen Therapien sowie die minimal-invasiven radiologischen Interventionen zur Verfügung. In der Übersicht sollen die einzelnen Therapieansätze erklärt, diskutiert und bewertet werden.

Abstract

Myomas of the uterus are benign tumors which very often occur among fertile women. In addition to surgical intervention other treatment modalities include medicinal (endocrine) and radiological interventions. This overview will review, discuss and evaluate these modalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Carbonell Esteve JL et al (2008) Mifepristone for the treatment of uterine leiomyomas: a randomized controlled trial. Obstet Gynecol 112(5):1029–1036

    Article  Google Scholar 

  2. Donnez J et al (2012) Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med 366(5):421–432

    Article  PubMed  CAS  Google Scholar 

  3. Donnez J et al (2012) Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med 366(5):409–420

    Article  PubMed  CAS  Google Scholar 

  4. Eckey T et al (2011) Non-invasive thermoablation of symptomatic uterine fibroids with magnetic resonance-guided high-energy ultrasound. Radiologe 51(7):610–619

    Article  PubMed  CAS  Google Scholar 

  5. Engman M et al (2009) Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial. Hum Reprod 24(8):1870–1879

    Article  PubMed  CAS  Google Scholar 

  6. Felberbaum RE et al (2001) Preoperative reduction of uterine fibroids in only 16 days by administration of a gonadotrophin-releasing hormone antagonist (Cetrotide). Reprod Biomed 3(1):14–18

    Article  CAS  Google Scholar 

  7. Fennessy FM et al (2007) Uterine leiomyomas: MR imaging-guided focused ultrasound surgery — results of different treatment protocols. Radiology 243(3):885–893

    Article  PubMed  Google Scholar 

  8. Fiscella K et al (2006) Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial. Obstet Gynecol 108(6):1381–1387

    Article  PubMed  CAS  Google Scholar 

  9. Flierman PA et al (2005) Rapid reduction of leiomyoma volume during treatment with the GnRH antagonist ganirelix. BJOG 112(5):638–642

    Article  PubMed  CAS  Google Scholar 

  10. Grigorieva V et al (2003) Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas. Fertil Steril 79(5):1194–1198

    Article  PubMed  Google Scholar 

  11. Gupta JK et al (2012) Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev 5:CD005073

    PubMed  Google Scholar 

  12. Hilário SG et al (2009) Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients. Fertil Steril 91(1):240–243

    Article  PubMed  Google Scholar 

  13. Jirecek S et al (2004) Raloxifene prevents the growth of uterine leiomyomas in premenopausal women. Fertil Steril 81(1):132–136

    Article  PubMed  CAS  Google Scholar 

  14. Lethaby A et al (2001) Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev 2:CD000547

    PubMed  Google Scholar 

  15. Magalhães J et al (2007) Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas. Contraception 75(3):193–198

    Article  PubMed  Google Scholar 

  16. Mara M et al (2006) Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol 126(2):226–233

    Article  PubMed  Google Scholar 

  17. Marshall LM et al (1998) A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril 70(3):432–439

    Article  PubMed  CAS  Google Scholar 

  18. Palomba S et al (2002) Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial. Hum Reprod 17(12):3213–3219

    Article  PubMed  CAS  Google Scholar 

  19. Palomba S et al. (2002) Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study. J Clin Endocrinol Metab 87(8):3603–3608

    Article  PubMed  CAS  Google Scholar 

  20. Parsanezhad ME et al. (2010) A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Fertil Steril 93(1):192–198

    Article  PubMed  CAS  Google Scholar 

  21. Rabe T et al. (2012) Ulipristalacetat bei symptomatischem Uterus myomatosus und bei myombedingter Hypermenorrhoe. J Reproduktionsmed Endokrinol 9(2):106–126

    Google Scholar 

  22. Steinauer J et al. (2004) Systematic review of mifepristone for the treatment of uterine leiomyomata. Obstet Gynecol 103(6):1331–1336

    Article  PubMed  CAS  Google Scholar 

  23. Tropeano G et al. (2012) Is myomectomy always the best choice for infertile women with symptomatic uterine fibroids? J Obstet Gynaecol Res 38(4):733–736

    Article  PubMed  Google Scholar 

  24. Tropeano G et al. (2008) Non-surgical management of uterine fibroids. Hum Reprod 14(3):259–274

    Google Scholar 

  25. Tropeano G et al. (2004) Uterine artery embolization for fibroids does not have adverse effects on ovarian reserve in regularly cycling women younger than 40 years. Fertil Steril 81(4):1055–1061

    Article  PubMed  Google Scholar 

  26. Wise LA et al. (2004) Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol 159(2):113–123

    Article  PubMed  Google Scholar 

  27. Zapata LB et al. (2010) Intrauterine device use among women with uterine fibroids: a systematic review. Contraception 82(1):41–55

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Keine Angaben

Author information

Authors and Affiliations

  1. Universitätsfrauenklinik Ulm, Prittwitzstr. 43, 89075, Ulm, Deutschland

    A. Wöckel, C. Scholz, K. Hancke & W. Janni

Authors
  1. A. Wöckel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Scholz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Hancke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. Janni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Wöckel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wöckel, A., Scholz, C., Hancke, K. et al. Uterine Leiomyome. Gynäkologe 45, 835–840 (2012). https://doi.org/10.1007/s00129-012-2993-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00129-012-2993-x

Schlüsselwörter

Keywords

Search

Navigation